Usually not. Because stem cell therapy for Peripheral Neuropathy is investigational, most private insurers and public health systems do not cover it — they typically reimburse only approved treatments. Two exceptions are worth checking: (1) an approved indication for your specific case, and (2) a registered clinical trial, where treatment and monitoring are often provided at no cost. For private programmes, plan for self-pay — model your true all-in cost (treatment + travel) in our calculator.
Indicative EU pricing is €3,000–€8,000 for treatment, varying by cell type, sessions and protocol.
Am I a candidate? → · Peripheral Neuropathy: full overview → · Peripheral Neuropathy cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.
Kostenlose ärztliche Prüfung